Cargando…
Metabolic control of gene transcription in non-alcoholic fatty liver disease: the role of the epigenome
Non-alcoholic fatty liver disease (NAFLD) is estimated to affect 24% of the global adult population. NAFLD is a major risk factor for the development of cirrhosis and hepatocellular carcinoma, as well as being strongly associated with type 2 diabetes and cardiovascular disease. It has been proposed...
Autores principales: | Sinton, Matthew C., Hay, David C., Drake, Amanda J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637519/ https://www.ncbi.nlm.nih.gov/pubmed/31319896 http://dx.doi.org/10.1186/s13148-019-0702-5 |
Ejemplares similares
-
Modelling non-alcoholic fatty liver disease in human hepatocyte-like cells
por: Lyall, Marcus J., et al.
Publicado: (2018) -
Transcriptional Regulation in Non-Alcoholic Fatty Liver Disease
por: Steensels, Sandra, et al.
Publicado: (2020) -
The Role of Lipid and Lipoprotein Metabolism in Non-Alcoholic Fatty Liver Disease
por: Perla, Francesco M., et al.
Publicado: (2017) -
Circadian Clock Genes in the Metabolism of Non-alcoholic Fatty Liver Disease
por: Shi, Dongmei, et al.
Publicado: (2019) -
Metabolic drivers of non-alcoholic fatty liver disease
por: Bence, Kendra K., et al.
Publicado: (2020)